Primo Biotechnology
Manufacturing · Taiwan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
14f no. 167 Dunhua N. Dist Rd, Taipei, T...Phone Number
+886 225371160Website
www.primobt.comRevenue
$9.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Primo Biotechnology
Primo Biotechnology is a biotech company specializing in the development and manufacturing of radiopharmaceuticals driving innovation in precision cancer care. Primo collaborates with both domestic and international partners to accelerate progress in precision oncology, leveraging its capabilities in drug development, clinical translation, and GMP manufacturing to support new therapeutics.Explore more
Primo Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Primo Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Primo Biotechnology had a recent Job posting/layoffs
Check out if Primo Biotechnology is spiking on competitors!
Check if Primo Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Primo Biotechnology launches new products
Congratulate Masked Content for being promoted to Masked Content at Primo Biotechnology
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Primo Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Primo Biotechnology recently announced quarterly report
Funding: Get notified immidiatlly once Primo Biotechnology has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Primo Biotechnology as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Primo Biotechnology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Primo Biotechnology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Primo Biotechnology.
Primo Biotechnology financials insights
Gather financial insights about Primo Biotechnology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$6.7M
Primo Biotechnology Tech Stack
A closer look at the technologies used by Primo Biotechnology
See more technologies
Primo Biotechnology News & Media
Primo Biotechnology Secures A Funding and Targets 2026 IPO to Strengthen Global Radiopharmaceutical Strategy
TAIPEI, Taiwan, July 02, 2025 (GLOBE NEWSWIRE) -- Primo Biotechnology Co., Ltd., a pioneering radiopharmaceutical company in Taiwan, announced the successful completion of its NT$220 million Series A funding round. With total capital raised now exceeding NT$500 million, including seed and early-stage investments, Primo is accelerating its path toward leadership in radioligand theranostics. The company also revealed plans to launch its IPO in 2026, leveraging public market resources to expand R&DPrimo Partners with ABX to Bring PB01 Closer to Taiwan’s Prostate Cancer Market
Primo partners with ABX to bring PB01 to Taiwan, enhancing prostate cancer diagnosis with PSMA PET imaging, leveraging Radelumin’s success in Europe.Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Primo Biotechnology
Sign Up For FreeTo access detailed company insights
Primo Biotechnology is a biotech company specializing in the development and manufacturing of radiopharmaceuticals driving innovation in precision cancer care. Primo collaborates with both domestic and international partners to accelerate progress in precision oncology, leveraging its capabilities in drug development, clinical translation, and GMP... Read More
